Arvind Arora

2.8k citations

45 papers · 996 indexed · h-index 17

Impact in

Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Cancer Research top 10%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Molecular Biology 21
- DNA Repair Mechanisms 16
Oncology 18
- Cancer-related Molecular Pathways 9

Co-authors: Srinivasan Madhusudan (21 shared papers)Ian O. Ellis (14 shared papers)Stephen Chan (13 shared papers)Paul M. Moseley (13 shared papers)Graham Ball (10 shared papers)Andrew R. Green (12 shared papers)Christina J. Perry (9 shared papers)Emad A. Rakha (12 shared papers)
Journals: Oncotarget (3 papers)Molecular Oncology (3 papers)International Orthopaedics (2 papers)Cancers (2 papers)Antioxidants and Redox Signaling (2 papers)
Partner nations: United Kingdom United States India

In The Last Decade

Arvind Arora

41 papers receiving 986 citations

Peers

Countries citing papers authored by Arvind Arora

Since Specialization

Citations

This map shows the geographic impact of Arvind Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Arora more than expected).

Fields of papers citing papers by Arvind Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Arora. The network helps show where Arvind Arora may publish in the future.

Co-authors

The 25 scholars most cited alongside Arvind Arora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arvind Arora Line = papers co-authored together Arvind Arora links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ABC-06 \| A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy. Journal of Clinical Oncology ·Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan, Paul J. Ross, Yuk Ting, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Justin S. Waters, Claire Hobbs, Safia Barber, David Ryder, John Ramage, Linda Davies, John Bridgewater, Juan W. Valle, (unknown)	2019	154
2	Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway Cancer Research ·Dongliang Mo, Hongbo Fang, Kaifeng Niu, Jing Liu, Meng Wu, Shiyou Li, Tienian Zhu, Mohammed A. Aleskandarany, Arvind Arora, Dileep N. Lobo, Srinivasan Madhusudan, Adayabalam S. Balajee, Zhenfen Chi, Yongliang Zhao	2016	74
3	Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer Molecular Oncology ·Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora, Devika Agarwal, Tao Chen, Paul M. Moseley, Christina J. Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad A. Rakha, Graham Ball, Ian O. Ellis, Nicola J. Curtin, Srinivasan Madhusudan	2014	71
4	The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays BMC Cancer ·Nilanjana Tewari, Abed M. Zaitoun, Arvind Arora, Srinivasan Madhusudan, Mohammad Ilyas, Dileep N. Lobo	2013	65
5	Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy Molecular Oncology ·Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Roslin Russell, Devika Agarwal, Paul M. Moseley, Christina J. Perry, Arvind Arora, Nouf H. Alsubhi, Claire Seedhouse, Emad A. Rakha, Andrew R. Green, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan	2014	65
6	ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers PubMed ·Tarek M.A. Abdel-Fatah, Arvind Arora, Paul M. Moseley, Clare Coveney, Christina J. Perry, Kerstie Johnson, Christopher Kent, Graham Ball, Stephen Chan, Srinivasan Madhusudan	2014	48
7	RECQL4 helicase has oncogenic potential in sporadic breast cancers The Journal of Pathology ·Arvind Arora, Devika Agarwal, Tarek MA Abdel‐Fatah, Huiming Lu, Deborah L. Croteau, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Lisa L. Wang, Yongliang Zhao, Adayabalam S. Balajee, Vilhelm A. Bohr, Srinivasan Madhusudan	2015	45
8	Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer Molecular Cancer Therapeutics ·Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Alaa T. Alshareeda, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan	2015	42
9	Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts Neoplasia ·Tarek M. Abdel-Fatah, Arvind Arora, Nouf H. Alsubhi, Devika Agarwal, Paul M. Moseley, Christina J. Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad A. Rakha, Graham Ball, Ian O. Ellis, Srinivasan Madhusudan	2014	36
10	Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer Oncotarget ·Raghavendra A. Shamanna, Huiming Lu, Deborah L. Croteau, Arvind Arora, Devika Agarwal, Graham Ball, Mohammed A. Aleskandarany, Ian O. Ellis, Yves Pommier, Srinivasan Madhusudan, Vilhelm A. Bohr	2016	36
11	5-Carboxylcytosine levels are elevated in human breast cancers and gliomas Clinical Epigenetics ·Maria Eleftheriou, Ana Jimenez Pascual, Lee M. Wheldon, Christina J. Perry, Abdulkadir Abakir, Arvind Arora, Andrew D. Johnson, Dorothee P. Auer, Ian O. Ellis, Srinivasan Madhusudan, Alexey Ruzov	2015	32
12	Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers Carcinogenesis ·Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal, Rachel Doherty, Deborah L. Croteau, Paul M. Moseley, Khalid Hameed, Andrew R. Green, Mohammed A. Aleskandarany, Emad A. Rakha, K. Patterson, Graham Ball, Stephen Chan, Ian O. Ellis, Vilhelm A. Bohr, Helen E. Bryant, Srinivasan Madhusudan	2015	31
13	Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer Molecular Oncology ·Nouf H. Alsubhi, Fiona K. Middleton, Tarek M.A. Abdel-Fatah, Peter Stephens, Rachel Doherty, Arvind Arora, Paul M. Moseley, Stephen Chan, Mohammed A. Aleskandarany, Andrew R. Green, Emad A. Rakha, Ian O. Ellis, Stewart G. Martin, Nicola J. Curtin, Srinivasan Madhusudan	2015	30
14	Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer Breast Cancer Research and Treatment ·Tarek M.A. Abdel-Fatah, Christina J. Perry, Paul M. Moseley, Kerstie Johnson, Arvind Arora, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan	2013	29
15	Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers? Antioxidants and Redox Signaling ·Tarek M.A. Abdel-Fatah, Christina J. Perry, Arvind Arora, Nicola Thompson, Rachel Doherty, Paul M. Moseley, Andrew R. Green, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan	2014	25
16	Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla BMC Cancer ·Sarah J. Storr, Abed M. Zaitoun, Arvind Arora, Lindy G. Durrant, Dileep N. Lobo, Srinivasan Madhusudan, Stewart G. Martin	2012	23
17	Measuring hip muscle strength in patients with femoroacetabular impingement and other hip pathologies Bone and Joint Research ·E. Mayne, Arman Memarzadeh, Pramin Raut, Arvind Arora, Vikas Khanduja	2017	19
18	Are DNA Repair Factors Promising Biomarkers for Personalized Therapy in Gastric Cancer? Antioxidants and Redox Signaling ·Tarek M.A. Abdel-Fatah, Arvind Arora, Ipek Gorguc, Rachel Abbotts, Sarah Beebeejaun, Sarah J. Storr, Vivek Mohan, Claire Hawkes, Irshad Soomro, Dileep N. Lobo, Simon L. Parsons, Srinivasan Madhusudan	2012	16
19	DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers Oncotarget ·Tarek M.A. Abdel-Fatah, Arvind Arora, Paul M. Moseley, Christina J. Perry, Emad A. Rakha, Andrew R. Green, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan	2015	16
20	Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers Molecular Cancer Therapeutics ·Arvind Arora, Swetha Parvathaneni, Mohammed A. Aleskandarany, Devika Agarwal, Reem Ali, Tarek M.A. Abdel-Fatah, Andrew R. Green, Graham Ball, Emad A. Rakha, Ian O. Ellis, Sudha Sharma, Srinivasan Madhusudan	2016	15

About Arvind Arora

Arvind Arora is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 996 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (16 papers), Cancer-related Molecular Pathways (9 papers), Hip disorders and treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Genetic factors in colorectal cancer (4 papers), Orthopaedic implants and arthroplasty (4 papers), BRCA gene mutations in cancer (3 papers) and Endodontics and Root Canal Treatments (3 papers). The work is most often cited by research in Oncology (456 citations), Cancer Research (195 citations), Molecular Biology (587 citations), Surgery (230 citations) and Pathology and Forensic Medicine (93 citations). Arvind Arora has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Srinivasan Madhusudan, Ian O. Ellis, Stephen Chan, Paul M. Moseley, Graham Ball, Andrew R. Green, Christina J. Perry, Emad A. Rakha, Tarek M.A. Abdel-Fatah and Devika Agarwal. Their work appears in journals such as Oncotarget, Molecular Oncology, International Orthopaedics, Cancers and Antioxidants and Redox Signaling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact